Kevin Quann
Overview
Explore the profile of Kevin Quann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
561
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Neupane B, Ventura K, Parr K, Lee J, Quann K, Chen C, et al.
Bone Marrow Transplant
. 2025 Jan;
PMID: 39881205
No abstract available.
2.
Peralta R, Xie B, Lontos K, Nieves-Rosado H, Spahr K, Joshi S, et al.
Nat Immunol
. 2024 Nov;
25(12):2297-2307.
PMID: 39516648
CD8 T cells are critical mediators of antitumor immunity but differentiate into a dysfunctional state, known as T cell exhaustion, after persistent T cell receptor stimulation in the tumor microenvironment...
3.
Quann K, Lontos K, Sehgal A, Raptis A, Im A, Redner R, et al.
Haematologica
. 2024 Aug;
109(12):4106-4111.
PMID: 39113675
No abstract available.
4.
Im A, Quann K, Agha M, Raptis A, Redner R, Hou J, et al.
Am J Hematol
. 2024 Jan;
99(3):380-386.
PMID: 38258329
Acute myeloid leukemia (AML) in older patients has a poor prognosis, low complete remission (CR) rates, and poor overall survival (OS). Preclinical studies have shown synergistic effects of epigenetic priming...
5.
Quann K, Sacirbegovic F, Shlomchik W
Blood Adv
. 2023 Sep;
7(17):5187-5188.
PMID: 37698891
No abstract available.
6.
Kuang C, Quann K, Liman A, Frye R, Alshoubaki N, Ramkumar M, et al.
Clin Case Rep
. 2020 Oct;
8(10):1984-1987.
PMID: 33088534
Patients with monoclonal gammopathy of renal significance should be treated with clone-directed therapy against sources of monoclonal proteins in order to prevent progression to more advanced monoclonal gammopathies and renal...
7.
Mogilyansky E, Clark P, Quann K, Zhou H, Londin E, Jing Y, et al.
Front Genet
. 2016 Sep;
7:143.
PMID: 27630665
Breast cancer type 2, early onset susceptibility gene (BRCA2) is a major component of the homologous recombination DNA repair pathway. It acts as a tumor suppressor whose function is often...
8.
Quann K, Jing Y, Rigoutsos I
Front Genet
. 2015 Aug;
6:242.
PMID: 26257769
MicroRNAs (miRNAs) are important post-transcriptional regulators of gene expression that act by degrading their RNA targets or by repressing the translation of messenger RNAs (mRNAs). Initially thought to primarily target...
9.
Londin E, Loher P, Telonis A, Quann K, Clark P, Jing Y, et al.
Proc Natl Acad Sci U S A
. 2015 Feb;
112(10):E1106-15.
PMID: 25713380
Two decades after the discovery of the first animal microRNA (miRNA), the number of miRNAs in animal genomes remains a vexing question. Here, we report findings from analyzing 1,323 short...
10.
Clark P, Loher P, Quann K, Brody J, Londin E, Rigoutsos I
Sci Rep
. 2014 Aug;
4:5947.
PMID: 25103560
To date, analyses of individual targets have provided evidence of a miRNA targetome that extends beyond the boundaries of messenger RNAs (mRNAs) and can involve non-Watson-Crick base pairing in the...